A look at natural language processing (NLP) technology's top potential use cases reveals how its destined to disrupt healthcare.It’s no secret that the big data wave had been building in healthcare for some time. What has somewhat remained a bit mysterious, however, is how innovators planned to stave the flood and make use of the sizeable data to help healthcare providers create efficiencies and improve outcomes. According to a recent Chilmark report, natural language processing (NLP) may be the
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
1DROP Raises $4.25M to Support Commercialization of Portable Medical Diagnostics Platform
1DROP, a life sciences startup developing and commercializing an easy to use laboratory quality, portable medical diagnostic testing platform has raised $4.25 million in Series A funding led by led by Christian Wildmoser (former partner CVC Capital Partners & Swiss Startup Group Investor). The round also included participation from private investors of the Swiss Startup Group including Dr. Hans-Peter Strebel (owner of On Your Marks), Beat Schillig (IFJ Institute for Young Entrepreneurs) and
Read More
Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel
Researchers at Exact Sciences Corp. and Mayo Clinic announced significant progress toward developing a panel of novel, blood-based, DNA biomarkers that could accurately detect hepatocellular carcinoma (HCC), the most common cancer that originates in the liver. The researchers detailed their findings during a presentation today at Digestive Disease Week.Using DNA extracted from the blood samples of 244 people, including 95 diagnosed across all stages of HCC, 51 with cirrhosis, and 98 healthy
Read More
Genetic Material Once Considered Junk Actually Could Hold Key to Cancer Drug Response
Material left out of common processes for sequencing genetic material in cancer tumors may actually carry important information about why only some people respond to immunotherapy, possibly offering better insight than the type of material that is being sequenced, according to a study by Mount Sinai researchers published on April 3 in Cell Reports. Sequencing a type of genetic material in cancer tumors called messenger RNA has transformed personalized cancer therapy and revealed biomarkers for
Read More
Gore Innovation Center, Kenzen Team Up to Develop Dermal Biometrics Patch
The Gore Innovation Center in Silicon Valley, today announced a joint development agreement and cash investment in digital health startup, Kenzen. W. L. Gore & Associates (Gore) engineers and scientists will work hand in hand with Kenzen, an innovator in precision health monitoring and insights, to develop a comprehensive wearable health monitoring system that employs biosensor data and predictive modeling to anticipate and prevent avoidable injuries and health conditions.By integrating
Read More
Precision Medicine Group Raises $275M to Support Biomarker-Guided Drug Development
Precision Medicine Group (PMG), an integrated team of experts focused on biomarker-guided drug development has raised $275 million in funding led by Berkshire Partners and TPG Growth and also includes significant participation from Precision’s co-founders and management team as well as original investors Oak Investment Partners and J.H. Whitney. . This investment will support the expansion of PMG’s global footprint and provide additional scale to accelerate the development, approval and
Read More
Mayo Clinic, sphingotec Collaborate for Evaluation & Use of Biomarkers to Improve Diagnosis
sphingotec GmbH , a biotechnology company that develops biomarkers for the detection and management of diseases, has recently signed an agreement with Mayo Clinic to collaborate on the evaluation and use of several biomarkers that may improve the diagnosis of certain disease states, including kidney disease, breast cancer, sepsis, and cardiovascular disease.As part of the agreement, Mayo Clinic will evaluate the biomarkers proenkephalin (penKid) and three others for research and potential
Read More
Philips Launches Informatics Platform to Advance Drug Research & Biomarker Discovery
Today, Philips has announced the launch of Xplore, a web-based image and data management platform that will help pharma and academic researchers speed up drug research and biomarker discovery through enhanced integration, visualization and analytics tools. Xplore v4.0 will be available commercially in July 2017. Customers have the option to purchase the basic package or with custom additions including a dedicated TMA module for enabling faster and streamlined research.As the industry continues
Read More
